Alteplázis

Alteplase is a medication used to break down blood clots. It is a type of tissue plasminogen activator, a protein that is naturally found in the body and plays a role in dissolving clots. Alteplase is administered intravenously, meaning it is given directly into a vein.

Its primary use is in the treatment of acute ischemic stroke, where a blood clot blocks blood flow to the brain. Prompt administration of alteplase can help to restore blood flow and reduce the severity of stroke-related disability. It is also used to treat acute myocardial infarction, commonly known as a heart attack, by dissolving clots in the coronary arteries. In addition, alteplase can be used to treat pulmonary embolism, a condition where a clot blocks an artery in the lungs.

The use of alteplase carries certain risks, most notably bleeding. Because it dissolves clots, it can also increase the risk of bleeding elsewhere in the body. Therefore, it is typically administered in a hospital setting by trained medical professionals who can carefully monitor the patient for any adverse effects. The decision to use alteplase is based on a careful assessment of the potential benefits versus the risks for each individual patient.